Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Revenue (2024 - 2026)

Beta Bionics' Revenue history spans 3 years, with the latest figure at $27.6 million for Q1 2026.

  • On a quarterly basis, Revenue rose 56.62% to $27.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $110.2 million, a 57.87% increase, with the full-year FY2025 number at $100.3 million, up 53.94% from a year prior.
  • Revenue hit $27.6 million in Q1 2026 for Beta Bionics, down from $32.1 million in the prior quarter.
  • Over the last five years, Revenue for BBNX hit a ceiling of $32.1 million in Q4 2025 and a floor of $12.9 million in Q1 2024.
  • Historically, Revenue has averaged $21.4 million across 3 years, with a median of $20.4 million in 2024.
  • The widest YoY moves for Revenue: up 63.14% in 2025, down 36.39% in 2025.
  • Tracing BBNX's Revenue over 3 years: stood at $20.4 million in 2024, then skyrocketed by 57.15% to $32.1 million in 2025, then fell by 13.99% to $27.6 million in 2026.
  • Business Quant data shows Revenue for BBNX at $27.6 million in Q1 2026, $32.1 million in Q4 2025, and $27.3 million in Q3 2025.